Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.0267 | 1 | 0.5 |
Loa Loa (eye worm) | nuclear receptor nhr-7B | 0.0221 | 0.7059 | 0.7059 |
Loa Loa (eye worm) | eukaryotic-type carbonic anhydrase | 0.0204 | 0.6012 | 0.6012 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Plasmodium vivax | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 0.0267 | 1 | 1 |
Schistosoma mansoni | casein kinase II beta subunit | 0.0267 | 1 | 1 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0204 | 0.6012 | 0.6012 |
Plasmodium falciparum | casein kinase II beta chain | 0.0267 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Loa Loa (eye worm) | Csnk2b protein | 0.0267 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0216 | 0.6748 | 0.6748 |
Trypanosoma brucei | Casein kinase II subunit beta, putative | 0.0267 | 1 | 1 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.0267 | 1 | 0.5 |
Onchocerca volvulus | Casein kinase II subunit beta homolog | 0.0267 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Brugia malayi | nuclear hormone receptor | 0.0221 | 0.7059 | 0.7059 |
Brugia malayi | Putative carbonic anhydrase 5 precursor | 0.0204 | 0.6012 | 0.6012 |
Toxoplasma gondii | ck2 beta subunit | 0.0267 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Entamoeba histolytica | casein kinase II regulatory subunit family protein | 0.0267 | 1 | 0.5 |
Echinococcus granulosus | casein kinase ii subunit beta | 0.0267 | 1 | 1 |
Echinococcus multilocularis | carbonic anhydrase II | 0.0204 | 0.6012 | 0.6012 |
Leishmania major | protein kinase ck2 regulatory subunit, putative | 0.0267 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Giardia lamblia | Casein kinase II beta chain | 0.0267 | 1 | 0.5 |
Echinococcus granulosus | carbonic anhydrase II | 0.0204 | 0.6012 | 0.6012 |
Trypanosoma cruzi | Casein kinase II subunit beta, putative | 0.0267 | 1 | 1 |
Brugia malayi | Eukaryotic-type carbonic anhydrase family protein | 0.0204 | 0.6012 | 0.6012 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Schistosoma mansoni | carbonic anhydrase II (carbonate dehydratase II) | 0.0204 | 0.6012 | 0.6012 |
Loa Loa (eye worm) | carbonic anhydrase 3 | 0.0204 | 0.6012 | 0.6012 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Plasmodium falciparum | casein kinase II beta chain | 0.0267 | 1 | 1 |
Plasmodium vivax | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Toxoplasma gondii | casein kinase ii regulatory subunit protein | 0.0267 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Trypanosoma cruzi | Casein kinase II subunit beta, putative | 0.0267 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Echinococcus multilocularis | casein kinase ii subunit beta | 0.0267 | 1 | 1 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Trichomonas vaginalis | casein kinase II beta chain, putative | 0.0267 | 1 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.